Regulatory considerations for pluripotent stem cell therapies
- PMID: 28552227
- DOI: 10.1016/bs.pbr.2016.12.008
Regulatory considerations for pluripotent stem cell therapies
Abstract
The development of pluripotent stem cell (PSC) therapies is rapidly advancing, and a number of PSC-derived cell products are currently being tested in clinical trials. The biological complexity of these therapies results in specific challenges in complying with regulatory guidelines. This includes the choice of starting material, reproducible and consistent manufacturing, and preclinical safety and efficacy assessment of the PSC-derived product. This review discusses current US cell therapy regulations and strategies for compliance with these regulations when developing PSC-derived products.
Keywords: Donor eligibility; FDA; GMP; GTP; Pluripotent stem cell; Regulatory.
© 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Regulatory considerations for the development of autologous induced pluripotent stem cell therapies.Regen Med. 2010 Jul;5(4):569-79. doi: 10.2217/rme.10.55. Regen Med. 2010. PMID: 20632860
-
2005 Donor Eligibility Requirements: Unintended Consequences for Stem Cell Development.Stem Cells Transl Med. 2015 Oct;4(10):1097-100. doi: 10.5966/sctm.2015-0045. Epub 2015 Aug 18. Stem Cells Transl Med. 2015. PMID: 26285658 Free PMC article.
-
Quality Assessment and Production of Human Cells for Clinical Use.Methods Mol Biol. 2018;1780:607-629. doi: 10.1007/978-1-4939-7825-0_28. Methods Mol Biol. 2018. PMID: 29856038
-
Concise review: making and using clinically compliant pluripotent stem cell lines.Stem Cells Transl Med. 2015 Apr;4(4):381-8. doi: 10.5966/sctm.2014-0202. Epub 2015 Feb 26. Stem Cells Transl Med. 2015. PMID: 25722426 Free PMC article. Review.
-
Considerations on chemistry, manufacturing, and control of stem cell products for Investigational New Drug application in China.Biologicals. 2020 Nov;68:3-8. doi: 10.1016/j.biologicals.2020.10.001. Epub 2020 Oct 20. Biologicals. 2020. PMID: 33097376 Review.
Cited by
-
Remodeling the Human Adult Stem Cell Niche for Regenerative Medicine Applications.Stem Cells Int. 2017;2017:6406025. doi: 10.1155/2017/6406025. Epub 2017 Sep 27. Stem Cells Int. 2017. PMID: 29090011 Free PMC article. Review.
-
The Manufacture of Xeno- and Feeder-Free Clinical-Grade Human Embryonic Stem Cell Lines: First Step for Cell Therapy.Int J Mol Sci. 2022 Oct 18;23(20):12500. doi: 10.3390/ijms232012500. Int J Mol Sci. 2022. PMID: 36293356 Free PMC article.
-
Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives.Biology (Basel). 2022 Jan 17;11(1):147. doi: 10.3390/biology11010147. Biology (Basel). 2022. PMID: 35053145 Free PMC article. Review.
-
Successes and Hurdles in Stem Cells Application and Production for Brain Transplantation.Front Neurosci. 2019 Nov 19;13:1194. doi: 10.3389/fnins.2019.01194. eCollection 2019. Front Neurosci. 2019. PMID: 31802998 Free PMC article. Review.
-
3D-Printing Graphene Scaffolds for Bone Tissue Engineering.Pharmaceutics. 2022 Aug 31;14(9):1834. doi: 10.3390/pharmaceutics14091834. Pharmaceutics. 2022. PMID: 36145582 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
